← [Archived Hypothesis]
Target: %s
Composite Score: 0.300
Price: $0.30▲85.9%
Citation Quality: Pending
Status: archived
Quality Report Card
click to collapse
D
Composite: 0.300
Top 90% of 1302 hypotheses
T3 Provisional
Single-source or model-inferred
Needs composite score ≥0.60 (current: 0.30), 1+ debate session for Supported
F
Mech. Plausibility 15%
0.00
Top 50%
F
Evidence Strength 15%
0.00
Top 50%
F
Novelty 12%
0.00
Top 50%
F
Feasibility 12%
0.00
Top 50%
F
Impact 12%
0.00
Top 50%
F
Druggability 10%
0.00
Top 50%
F
Safety Profile 8%
0.00
Top 50%
F
Competition 6%
0.00
Top 50%
F
Data Availability 5%
0.00
Top 50%
F
Reproducibility 5%
0.00
Top 50%
Evidence
3 supporting
|
2 opposing
Citation quality: 40%
Debates
0 sessions
No debates yet
Description
No description available
No AI visual card yet
Generate visual card ✦
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
Mechanistic
0.07 (15%)
Evidence
0.07 (15%)
Novelty
0.05 (12%)
Feasibility
0.05 (12%)
Impact
0.05 (12%)
Druggability
0.04 (10%)
Safety
0.04 (8%)
Competition
0.03 (6%)
Data Avail.
0.02 (5%)
Reproducible
0.02 (5%)
0.300
composite
Evidence 5
Debates 0
Market 16
Clinical Trials 0
Papers 5
Notebooks 0
Arenas
5 citations
5 with PMID
Validation: 40%
3 supporting / 2 opposing
High Medium Low
High Medium Low
Evidence Matrix
— sortable by strength/year, click Abstract to expand
Evidence Types
Claim Stance Category Source Strength ↕ Year ↕ Quality ↕ PMIDs Abstract Retroperitoneal Dedifferentiated Liposarcoma. Supporting MECH Am J Clin Patho… - 2021 - PMID:34125170 - The systems biology simulation core library. Supporting MECH Bioinformatics - 2022 - PMID:34554191 - Wilder Penfield and the vascular hypothesis of foc… Supporting MECH J Neurosurg - 2019 - PMID:30611132 - Salpingectomy for the Primary Prevention of Ovaria… Opposing CLIN JAMA Surg - 2023 - PMID:37672283 - Outcomes of 1- Versus 2-Stage Revision Anterior Cr… Opposing EPID Am J Sports Med - 2021 - PMID:32673067 -
Legacy Card View — expandable citation cards
✓ Supporting Evidence
3
Retroperitoneal Dedifferentiated Liposarcoma. The systems biology simulation core library. Wilder Penfield and the vascular hypothesis of focal epilepsy.
✗ Opposing Evidence
2
Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review.
Outcomes of 1- Versus 2-Stage Revision Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta… ▼ Outcomes of 1- Versus 2-Stage Revision Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis.
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
No linked debates yet. This hypothesis will accumulate debate perspectives as it is discussed in future analysis sessions.
Price History
0.08 0.17 0.25
evidence: market_dynamics (2026-04-13T20:07) evidence: market_dynamics (2026-04-13T21:14) debate: market_dynamics (2026-04-13T21:59) debate: market_dynamics (2026-04-13T23:58) evidence: market_dynamics (2026-04-14T02:57) score_update: market_dynamics (2026-04-14T03:33) score_update: market_dynamics (2026-04-14T05:11) score_update: market_dynamics (2026-04-14T06:12) debate: market_dynamics (2026-04-14T07:40) 0.33
0.00
2026-04-13 2026-04-14 2026-04-22
Market Price Score evidence debate
16 events
⚡ Price Movement Log
Recent 9 events
Event
Price
Change
Source
Time
💬
Debate Round
$0.314
▲ 94.7% market_dynamics
2026-04-14 07:40
📊
Score Update
$0.161
▲ 578.2% market_dynamics
2026-04-14 06:12
📊
Score Update
$0.024
▼ 90.3% market_dynamics
2026-04-14 05:11
📊
Score Update
$0.245
▼ 5.0% market_dynamics
2026-04-14 03:33
📄
New Evidence
$0.258
▲ 116.2% market_dynamics
2026-04-14 02:57
💬
Debate Round
$0.119
▲ 77.9% market_dynamics
2026-04-13 23:58
💬
Debate Round
$0.067
▲ 36.7% market_dynamics
2026-04-13 21:59
📄
New Evidence
$0.049
▼ 69.6% market_dynamics
2026-04-13 21:14
📄
New Evidence
$0.161
market_dynamics
2026-04-13 20:07
Clinical Trials (0)
🔍 Enrich from ClinicalTrials.gov
No clinical trials data available
📓 Linked Notebooks (0)
No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.
Related Hypotheses
No related hypotheses found
Estimated Development
🧪 Falsifiable Predictions
No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.
Knowledge Subgraph (0 edges)
No knowledge graph edges recorded